MedPath

Drexel University College of Medicine

Drexel University College of Medicine logo
🇺🇸United States
Ownership
Private, Subsidiary
Established
1848-01-01
Employees
-
Market Cap
-
Website
http://www.drexelmed.edu

Clinical Trials

28

Active:0
Completed:18

Trial Phases

4 Phases

Phase 1:2
Phase 2:6
Phase 4:2
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (15 trials with phase data)• Click on a phase to view related trials

Phase 2
6 (40.0%)
Not Applicable
5 (33.3%)
Phase 1
2 (13.3%)
Phase 4
2 (13.3%)

Effect of Intravenous Lidocaine, Used to Attenuate Pain With Propofol Injection, on Defibrillation Threshold Testing

Phase 1
Terminated
Conditions
Pain
Interventions
Drug: Placebo
First Posted Date
2017-04-17
Last Posted Date
2017-05-09
Lead Sponsor
Drexel University College of Medicine
Target Recruit Count
19
Registration Number
NCT03117166
Locations
🇺🇸

Hahnemann University Hospital, Philadelphia, Pennsylvania, United States

Induction Chemotherapy Followed by Cetuximab and Radiation Therapy for Head and Neck Cancer

Phase 2
Completed
Conditions
Head and Neck Cancer
Interventions
Radiation: Radiotherapy
Biological: Cetuximab
Drug: Erythropoetin
First Posted Date
2011-11-08
Last Posted Date
2017-05-09
Lead Sponsor
Drexel University College of Medicine
Target Recruit Count
1
Registration Number
NCT01467115
Locations
🇺🇸

Hahnemann University Hospital, Philadelphia, Pennsylvania, United States

Heart Rate Variability Changes During Cardiac Surgery And The Incidence Of Post-Operative Cardiac Arrhythmias

Not Applicable
Withdrawn
Conditions
Cardiac Arrhythmia
First Posted Date
2011-05-25
Last Posted Date
2013-06-14
Lead Sponsor
Drexel University College of Medicine
Registration Number
NCT01359683
Locations
🇺🇸

Hahnemann University Hospital, Philadelphia, Pennsylvania, United States

Levetiracetam: The Anti-Convulsant of Choice for Elderly Patients With Dementia

Phase 4
Completed
Conditions
Epilepsy
Interventions
First Posted Date
2011-03-18
Last Posted Date
2018-10-12
Lead Sponsor
Drexel University College of Medicine
Target Recruit Count
24
Registration Number
NCT01318408
Locations
🇺🇸

Drexel University College of Medicine, Dept of Neurology, Philadelphia, Pennsylvania, United States

Study to Evaluate the Safety of Chronic Administration of Simulect to Subjects Receiving a First Kidney Transplant

Phase 2
Terminated
Conditions
End Stage Renal Disease
Interventions
First Posted Date
2009-06-26
Last Posted Date
2015-02-10
Lead Sponsor
Drexel University College of Medicine
Target Recruit Count
5
Registration Number
NCT00928811
Locations
🇺🇸

Drexel University College of Medicine, Philadelphia, Pennsylvania, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath